Cipher Pharmaceuticals Stock Performance

CPHRF Stock  USD 10.67  0.18  1.72%   
On a scale of 0 to 100, Cipher Pharmaceuticals holds a performance score of 8. The firm shows a Beta (market volatility) of 0.5, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Cipher Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding Cipher Pharmaceuticals is expected to be smaller as well. Please check Cipher Pharmaceuticals' sortino ratio, skewness, price action indicator, as well as the relationship between the potential upside and rate of daily change , to make a quick decision on whether Cipher Pharmaceuticals' price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Cipher Pharmaceuticals are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, Cipher Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
  

Cipher Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  953.00  in Cipher Pharmaceuticals on November 17, 2025 and sell it today you would earn a total of  114.00  from holding Cipher Pharmaceuticals or generate 11.96% return on investment over 90 days. Cipher Pharmaceuticals is currently producing 0.1991% returns and takes up 1.8554% volatility of returns over 90 trading days. Put another way, 16% of traded otc stocks are less volatile than Cipher, and 96% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Cipher Pharmaceuticals is expected to generate 2.43 times more return on investment than the market. However, the company is 2.43 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.13 per unit of risk.

Cipher Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Cipher OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 10.67 90 days 10.67 
about 39.33
Based on a normal probability distribution, the odds of Cipher Pharmaceuticals to move above the current price in 90 days from now is about 39.33 (This Cipher Pharmaceuticals probability density function shows the probability of Cipher OTC Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Cipher Pharmaceuticals has a beta of 0.5 suggesting as returns on the market go up, Cipher Pharmaceuticals average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cipher Pharmaceuticals will be expected to be much smaller as well. Additionally Cipher Pharmaceuticals has an alpha of 0.1211, implying that it can generate a 0.12 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Cipher Pharmaceuticals Price Density   
       Price  

Predictive Modules for Cipher Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cipher Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
8.8110.6712.53
Details
Intrinsic
Valuation
LowRealHigh
8.6610.5212.38
Details

Cipher Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Cipher Pharmaceuticals is not an exception. The market had few large corrections towards the Cipher Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cipher Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cipher Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.12
β
Beta against Dow Jones0.50
σ
Overall volatility
0.48
Ir
Information ratio 0.05

Cipher Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cipher Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cipher Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
About 44.0% of the company shares are held by company insiders
Latest headline from news.google.com: Motorola Solutions MSI Stock Price, Company Overview News - Forbes

Cipher Pharmaceuticals Fundamentals Growth

Cipher OTC Stock prices reflect investors' perceptions of the future prospects and financial health of Cipher Pharmaceuticals, and Cipher Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cipher OTC Stock performance.

About Cipher Pharmaceuticals Performance

By analyzing Cipher Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Cipher Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cipher Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cipher Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cipher Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada. Cipher Pharmaceuticals Inc. was founded in 2000 and is headquartered in Oakville, Canada. Companhia Siderurgica is traded on OTC Exchange in the United States.

Things to note about Cipher Pharmaceuticals performance evaluation

Checking the ongoing alerts about Cipher Pharmaceuticals for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for Cipher Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
About 44.0% of the company shares are held by company insiders
Latest headline from news.google.com: Motorola Solutions MSI Stock Price, Company Overview News - Forbes
Evaluating Cipher Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Cipher Pharmaceuticals' otc stock performance include:
  • Analyzing Cipher Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cipher Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Cipher Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Cipher Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cipher Pharmaceuticals' management team can help you assess the OTC Stock's leadership.
  • Pay attention to analyst opinions and ratings of Cipher Pharmaceuticals' otc stock. These opinions can provide insight into Cipher Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Cipher Pharmaceuticals' otc stock performance is not an exact science, and many factors can impact Cipher Pharmaceuticals' otc stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Cipher OTC Stock analysis

When running Cipher Pharmaceuticals' price analysis, check to measure Cipher Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cipher Pharmaceuticals is operating at the current time. Most of Cipher Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Cipher Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cipher Pharmaceuticals' price. Additionally, you may evaluate how the addition of Cipher Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.